This site is intended for health professionals only
Friday 28 October 2016 Instagram
Share |

Child drug reactions guidance simplified

Child drug reactions guidance simplified

The Medicines and Healthcare products Regulatory Agency (MHRA) has announced new simplified guidance for healthcare professionals reporting suspected adverse drug reactions (ADRs) in children to its Yellow Card Scheme.

Changes to the guidelines follow a recent workshop with paediatric specialists, healthcare professionals and patient organisations who concluded that reporting all suspected ADRs in children was considered impractical for busy healthcare professionals and potentially acted as a barrier to reporting.

Ads by Google

You are leaving

You are currently leaving the Nursing in Practice site. Are you sure you want to proceed?